Food and Drug Regulations

C.01.041 (1) In this section and sections C.01.041.1 to C.01.046, Schedule F Drug means a drug listed or described in Schedule F to these Regulations.

(1.1) Subject to sections C.01.043 and C.01.046, no person shall sell a substance containing a Schedule F Drug unless

• (a) the sale is made pursuant to a verbal or written prescription received by the seller; and

• (b) where the prescription has been transferred to the seller under section C.01.041.1, the requirements of section C.01.041.2 have been complied with.

(2) Where the prescription for a Schedule F Drug is written, the person selling the drug shall retain the prescription for at least two years from the date of filling.

(3) Where the prescription for a Schedule F Drug is verbal, the person to whom the prescription is communicated by the practitioner shall forthwith reduce the prescription to writing and the person selling the drug shall retain that written prescription for a period of at least two years from the date of filling.

(4) The person reducing a verbal prescription to writing shall indicate on the written prescription

• (a) the date and number of the prescription;

• (b) the name and address of the person for whose benefit the prescription is given;

• (c) the proper name, common name or brand name of the specified drug and the quantity thereof;

• (d) his name and the name of the practitioner who issued the prescription; and

• (e) the directions for use given with the prescription, including whether or not the practitioner authorized the refilling of the prescription and, if the prescription is to be refilled, the number of times it may be refilled.

(5) Subsections (1.1) to (4) do not apply to a substance containing

• (a) chloral hydrate in preparations for external use, where it constitutes not more than one per cent of the substance, or

• (b) hexachlorophene and its salts, where it constitutes not more than 0.75 per cent of the substance, calculated as hexachlorophene.